These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30144273)

  • 1. Studies on the Substrate Selectivity of the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Catalytic Domain.
    Abboud MI; Chowdhury R; Leung IKH; Lippl K; Loenarz C; Claridge TDW; Schofield CJ
    Chembiochem; 2018 Nov; 19(21):2262-2267. PubMed ID: 30144273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.
    Chowdhury R; Leung IK; Tian YM; Abboud MI; Ge W; Domene C; Cantrelle FX; Landrieu I; Hardy AP; Pugh CW; Ratcliffe PJ; Claridge TD; Schofield CJ
    Nat Commun; 2016 Aug; 7():12673. PubMed ID: 27561929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
    Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
    Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.
    Pektas S; Knapp MJ
    J Inorg Biochem; 2013 Sep; 126():55-60. PubMed ID: 23787140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.
    Scotti JS; Leung IK; Ge W; Bentley MA; Paps J; Kramer HB; Lee J; Aik W; Choi H; Paulsen SM; Bowman LA; Loik ND; Horita S; Ho CH; Kershaw NJ; Tang CM; Claridge TD; Preston GM; McDonough MA; Schofield CJ
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13331-6. PubMed ID: 25197067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.
    Cockman ME; Lippl K; Tian YM; Pegg HB; Figg WD; Abboud MI; Heilig R; Fischer R; Myllyharju J; Schofield CJ; Ratcliffe PJ
    Elife; 2019 Sep; 8():. PubMed ID: 31500697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
    Strowitzki MJ; Cummins EP; Taylor CT
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and regulation of prolyl hydroxylase domain proteins.
    Fong GH; Takeda K
    Cell Death Differ; 2008 Apr; 15(4):635-41. PubMed ID: 18259202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
    Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
    Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
    Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
    Flashman E; Hoffart LM; Hamed RB; Bollinger JM; Krebs C; Schofield CJ
    FEBS J; 2010 Oct; 277(19):4089-99. PubMed ID: 20840591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
    Yu M; Lun J; Zhang H; Zhu L; Zhang G; Fang J
    Int J Biochem Cell Biol; 2021 Jun; 135():105982. PubMed ID: 33894356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.
    Wu Y; Li Z; McDonough MA; Schofield CJ; Zhang X
    J Med Chem; 2021 Jun; 64(11):7189-7209. PubMed ID: 34029087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases.
    Flashman E; Bagg EA; Chowdhury R; Mecinović J; Loenarz C; McDonough MA; Hewitson KS; Schofield CJ
    J Biol Chem; 2008 Feb; 283(7):3808-15. PubMed ID: 18063574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from
    Liu T; Abboud MI; Chowdhury R; Tumber A; Hardy AP; Lippl K; Lohans CT; Pires E; Wickens J; McDonough MA; West CM; Schofield CJ
    J Biol Chem; 2020 Dec; 295(49):16545-16561. PubMed ID: 32934009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Characterization of Hypoxia Inducible Factor α-Prolyl Hydroxylase Domain 2 Interaction through MD Simulations.
    Camagni GF; Minervini G; Tosatto SCE
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia.
    Ariazi JL; Duffy KJ; Adams DF; Fitch DM; Luo L; Pappalardi M; Biju M; DiFilippo EH; Shaw T; Wiggall K; Erickson-Miller C
    J Pharmacol Exp Ther; 2017 Dec; 363(3):336-347. PubMed ID: 28928122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.